iBio (IBIO) Invested Capital (2022 - 2025)

iBio's (IBIO) quarterly Invested Capital came in at $16000.0 in Q3 2025, down 91.21% year-on-year from $182000.0 in Q3 2024, and down 75.0% on a QoQ basis from $64000.0 in Q2 2025.

iBio (IBIO) Invested Capital (2022 - 2025) Analysis & Trends

iBio (IBIO) has 4 years of Invested Capital data on file, last reported at $16000.0 in Q3 2025.

  • On a quarterly basis, Invested Capital fell 91.21% year-over-year to $16000.0 in Q3 2025; TTM through Mar 2026 was $80000.0, a 87.2% decrease from a year earlier, with the FY2025 full-year figure at $64000.0, down 64.04% from the prior year.
  • Invested Capital for Q3 2025 stood at $16000.0, down from $64000.0 in the prior quarter.
  • Over the last five years, Invested Capital for IBIO reached as high as $814000.0 in Q3 2022 and fell as low as $16000.0 in Q3 2025.
  • Historically, Invested Capital has averaged $209875.0 across 4 years, with a median of $157500.0 in 2023.
  • Across the five-year window, Invested Capital increased 11.25% in 2024 and slumped 91.21% in 2025, its largest moves.
  • Year by year, Invested Capital stood at $814000.0 in 2022, then tumbled by 80.34% to $160000.0 in 2023, then declined by 3.12% to $155000.0 in 2024, then slumped by 89.68% to $16000.0 in 2025.
  • Per Business Quant data, the three most recent Invested Capital figures were $16000.0 in Q3 2025, $64000.0 in Q2 2025, and $110000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 110.96 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 116.14 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 iBio 172.22 Mn 172.22 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 16,000.00
Jun 30, 2025 64,000.00
Mar 31, 2025 110,000.00
Dec 31, 2024 155,000.00
Sep 30, 2024 182,000.00
Jun 30, 2024 178,000.00
Jun 30, 2023 160,000.00
Sep 30, 2022 814,000.00